Healthcare provider profile · identity verified

Melissa E. Hurd, M.D.

Family Practice · VISTA, CA · NPI 1487643698

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	455	138
Amlodipine Besylate	Amlodipine Besylate	354	108
Levothyroxine Sodium	Levothyroxine Sodium	323	90
Rosuvastatin Calcium	Rosuvastatin Calcium	269	94
Losartan Potassium	Losartan Potassium	254	79
Lisinopril	Lisinopril	224	68
Gabapentin	Gabapentin	187	61
Omeprazole	Omeprazole	168	64
Alendronate Sodium	Alendronate Sodium	164	58
Metformin Hcl	Metformin Hcl	143	40
Albuterol Sulfate Hfa	Albuterol Sulfate	129	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	128	29
Hydrochlorothiazide	Hydrochlorothiazide	120	34
Metoprolol Succinate	Metoprolol Succinate	116	36
Simvastatin	Simvastatin	111	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	95	29
Furosemide	Furosemide	92	34
Sertraline Hcl	Sertraline Hcl	91	21
Ozempic	Semaglutide	85	20
Alprazolam	Alprazolam	82	22
Zolpidem Tartrate	Zolpidem Tartrate	80	20
Famotidine	Famotidine	79	31
Carvedilol	Carvedilol	75	21
Potassium Chloride	Potassium Chloride	75	32
Glipizide	Glipizide	73	28
Fluticasone Propionate	Fluticasone Propionate	69	33
Eliquis	Apixaban	68	21
Olmesartan Medoxomil	Olmesartan Medoxomil	67	28
Duloxetine Hcl	Duloxetine Hcl	65	23
Trazodone Hcl	Trazodone Hcl	65	18
Escitalopram Oxalate	Escitalopram Oxalate	63	24
Celecoxib	Celecoxib	60	18
Tramadol Hcl	Tramadol Hcl	59	18
Ibuprofen	Ibuprofen	55	23
Pantoprazole Sodium	Pantoprazole Sodium	53	19
Baclofen	Baclofen	51	18
Clopidogrel	Clopidogrel Bisulfate	50	12
Ipratropium Bromide	Ipratropium Bromide	47	13
Jardiance	Empagliflozin	47	17
Azithromycin	Azithromycin	46	38
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	12
Valacyclovir	Valacyclovir Hcl	44	17
Atenolol	Atenolol	43	12
Tamsulosin Hcl	Tamsulosin Hcl	43	14
Donepezil Hcl	Donepezil Hcl	42	18
Ketoconazole	Ketoconazole	42	23
Metoprolol Tartrate	Metoprolol Tartrate	42	15
Metformin Hcl Er	Metformin Hcl	41	17
Pravastatin Sodium	Pravastatin Sodium	40	12
Allopurinol	Allopurinol	39	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	28
Estradiol	Estradiol	39	18
Bupropion Xl	Bupropion Hcl	38	14
Synthroid	Levothyroxine Sodium	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	11
Montelukast Sodium	Montelukast Sodium	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	23
Meloxicam	Meloxicam	36	12
Lovastatin	Lovastatin	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	11
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	20
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Prednisone	Prednisone	32	19
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	30	11
Memantine Hcl	Memantine Hcl	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	25
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	26	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	11
Spironolactone	Spironolactone	25	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Cephalexin	Cephalexin	24	18
Rybelsus	Semaglutide	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Buspirone Hcl	Buspirone Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Felodipine Er	Felodipine	19	suppressed
Naproxen	Naproxen	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Ramipril	Ramipril	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Sotalol	Sotalol Hcl	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	11
Finasteride	Finasteride	17	suppressed
Mupirocin	Mupirocin	17	13
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Topiramate	Topiramate	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Primidone	Primidone	14	suppressed
Valsartan	Valsartan	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Amoxicillin	Amoxicillin	13	12
Aripiprazole	Aripiprazole	13	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Methimazole	Methimazole	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Nystatin	Nystatin	13	11
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Horizant	Gabapentin Enacarbil	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Risperidone	Risperidone	12	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error